However, high PD-L1 expression is associated with poor survival outcomes in many cancers, including renal, esophageal, breast, ovarian, and prostate cancers [29, 30], suggesting that hypomethylation of PD-L1 might lead to poor survival outcomes. This evidence concerns the gene CD274 and cancer.